title: The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges.
abstract: Herpes simplex virus type 2 (HSV-2) invades human genital tract mucosa and following local replications can be rapidly transmitted via peripheral nerve axons to the sacral ganglia where it can establish latency. Reactivation of the latent viral reservoir results in recurrent ulcers in the genital region. Innate immunity, the first line of defence during both primary and recurrent genital herpes infections, is crucial during the period of acute infection to limit early virus replication and to facilitate the development of an appropriate specific acquired immunity. Recent developments in immunology reveal that the mammalian innate immune systems use Toll-like receptor (TLR) to specifically sense evolutionary conserved molecules such as bacterial DNA in pathogens. Recently, local-vaginal delivery of CpG containing oligodeoxynucleotide (ODN), a synthetic mimic of bacterial DNA, holds substantial promise as a strong inducer of innate immunity against genital herpes infections in the animal models of the disease. These preclinical observations provide a scientific ground work for introduction of this novel intervention strategy to clinic. This review aims to highlight recent developments and future challenges in use of immunostimulatory CpG ODN for inducing immunity against genital herpes infection and disease.
authors.affiliation: Department of Medical Microbiology and Immunology, Göteborg University Vaccine Research Institute, Göteborg University, Medicinaregatan 7A, 405 30 Göteborg, Sweden. ali.harandi@microbio.gu.se
authors.forename: Ali M
authors.initials: AM
authors.lastname: Harandi
mesh_terms: D000276:Adjuvants, Immunologic; D000282:Administration, Intravaginal; D018899:CpG Islands / Q000235:genetics; D005260:Female; D006558:Herpes Genitalis / Q000276:immunology*; D018258:Herpesvirus 2, Human; D006801:Humans; D007113:Immunity, Innate; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage* / Q000276:immunology*
chemical_list: D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D009838:Oligodeoxyribonucleotides